Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Privia Health Group, Inc.PRVA · Entity 1532 | EVP & General Counsel | March 10, 2026 | March 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Privia Health Group, Inc.
Report date March 10, 2026 · Filed March 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.01 par value per shareSEC Table I · non-derivative | Direct | 111,979 |
Reported balance
After 2026-03-10 transaction · row 1
1 source rowRow 1 · 2026-03-10 · Grant · Acquired 28,268 · Balance 111,979 F1: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2026 Filed Mar 12, 2026 17:46 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 28,268 | $0.00 | $0.00 |
DisclosureSEC source: 0002009323-26-000002 · wk-form4_1773351998.xml · nonDerivative · entry 1 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,979 F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. Read SEC document |
| March 09, 2026 Filed Mar 10, 2026 16:01 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 4,949 | $22.84 | $113,035.16 |
DisclosureSEC source: 0001759655-26-000016 · wk-form4_1773172858.xml · nonDerivative · entry 2 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,711 F1 · kind: The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| March 06, 2026 Filed Mar 10, 2026 16:01 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 4,394 | $23.15 | $101,721.10 |
DisclosureSEC source: 0001759655-26-000016 · wk-form4_1773172858.xml · nonDerivative · entry 1 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,660 F1 · kind: The sales reported in this Form 4 represent nondiscretionary sales of shares required to be sold by the Reporting Person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| March 11, 2025 Filed Mar 12, 2025 17:06 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 2,438 | $23.88 | $58,219.44 |
DisclosureSEC source: 0001759655-25-000030 · wk-form4_1741813581.xml · nonDerivative · entry 2 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,054 F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 17:06 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | SaleCommon Stock, $0.01 par value per share | 2,529 | $24.53 | $62,036.37 |
DisclosureSEC source: 0001759655-25-000030 · wk-form4_1741813581.xml · nonDerivative · entry 1 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,492 F1 · kind: The sales reported in this Form 4 represent a nondiscretionary sale of shares required to be sold by the Reporting Person pursuant to "sell to cover" transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 08:37 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 25,073 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-25-000026 · wk-form4_1741354652.xml · nonDerivative · entry 1 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,021 F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. Read SEC document |
| March 08, 2024 Filed Mar 15, 2024 17:03 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 28,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-24-000029 · wk-form4_1710536622.xml · nonDerivative · entry 1 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,948 F1 · shares: Reflects restricted stock units under the 2021 Omnibus Incentive Plan that will vest in substantially equal annual installments on the first, second and third anniversaries of the grant date, generally subject to continued service throughout such dates. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 16:27 UTC | Privia Health Group, Inc. PRVA · Entity 1532 | GrantCommon Stock, $0.01 par value per share | 44,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001759655-24-000016 · wk-form4_1706736410.xml · nonDerivative · entry 1 Fargis Edward C · CIK 0002009323 · EVP & General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,404 F1 · shares: Represents restricted stock units granted under the Issuer's 2021 Omnibus Incentive Plan that will vest on the third anniversary of the grant date, generally subject to continued service through such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.